Study Name:
An International, Multicenter, Phase II, Randomized, Parallel-Arm Trial Investigating The Role Of Two Different Metronomic Chemotherapy Regimens In Locally Advanced Or Metastatic Triple Negative Breast Cancer Patients (TNBC) As Maintenance Therapy After First Line Treatment (VICTOR-3 study)

Phase:
Phase 2 Clinical Trial

EudraCT number:
2016-001864-12

National Investigator Coordinator:
Dr. Margarida Damasceno (Centro Hospitalar São João)

Participating countries:
Italy, Spain, Portugal

Sites in Portugal:
Centro Hospital Lisboa Norte - Hospital Santa Maria, Centro Hospitalar Lisboa Ocidental - Hospital de São Francisco Xavier, Hospital Beatriz Ângelo, Centro Hospitalar São João, IPO Coimbra, IPO Porto, Centro Hospitalar do Porto.

Sponsor:
IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milano

Status:
Finished